Suven Life Sciences to set up subsidiary in US, all set to invest USD 75 millon in venture
- Country:
- India
Suven Life Sciences Saturday said it will create a wholly-owned subsidiary in the US and will infuse USD 75 million (about Rs 525 crore) in its new business. The board of directors at its meeting held on Saturday has taken on record the approval for creation of wholly owned subsidiary (WOS) Suven Pharma, Inc, a Delaware company in the US under Contract Research And Manufacturing Services (CRAMS) division, the company said in a regulatory filing. The board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions, it added.
(With inputs from agencies.)
Advertisement
ALSO READ
Bank fraud: ED attaches assets of Madhya Pradesh-based newspaper publishing company
Nazara games subsidiary to acquire Ultimate Teen Patti IP from Games24x7
Lionsgate Play partners telecom company Smart to strengthen presence in Philippines
Trump to be deposed in dispute with media company co-founders
Is EC a 'subsidiary organisation' of BJP, asks Atishi after being served show-cause notice